The Asia-Pacific with an intermediate to high prevalence, represents three-quarters of chronic hepatitis B (CHB)-positive subjects worldwide.
Novotech Awarded Cell & Gene Therapy CRO Excellence 2023
Singapore – 19 September 2023 - Novotech, the leading Asia Pacific centred biote
Read more